Ischemic Strokes While on NOAC - How Compliance Matters

Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 23, 2020

Keywords

ClinConnect Summary

This clinical trial, titled "Ischemic Strokes While on NOAC - How Compliance Matters," is focused on understanding the trends and causes of ischemic strokes (a type of stroke caused by blocked blood flow to the brain) in patients using NOACs (new oral anticoagulants). The study aims to gather important information about how these strokes occur, the characteristics of the patients affected, and the best treatment options available. This knowledge will help healthcare providers identify ways to prevent these strokes and improve how they manage patients who experience them.

To be eligible for this trial, participants must be ethnic Chinese individuals who have a known condition called atrial fibrillation (AF), which increases the risk of strokes, and who have had an ischemic stroke. Unfortunately, those who are not ethnic Chinese or who have experienced a different type of stroke called a hemorrhagic stroke will not be able to participate. If you or someone you know meets these criteria, joining the study could provide valuable insights for future stroke prevention and treatment efforts. Participants can expect to contribute to important research that could help many others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who were ethnic Chinese
• • 2. Patients with known AF
• • 3. Patient who suffered from ischaemic stroke
• Exclusion Criteria:
• • 1. Patient who are non-ethnic Chinese
• • 2. Patient who suffered from haemorrhagic stroke